To view this email as a web page, click here.

Implementing a Same-Day Biopsy Program to Reduce Disparities in Breast Cancer Care

A same-day biopsy program for women helped reduce disparities related to age, race, and insurance type in breast cancer care.

Pembrolizumab Provides Hope for PD-L1–Positive Cervical Cancer Patients

The phase II KEYNOTE-158 basket trial evaluated single-agent pembrolizumab in patients with previously treated advanced cervical cancer.

IN CASE YOU MISSED IT

Is Radiation Safe as a Bridging Strategy to CAR T Therapy in Advanced DLBCL?

Researchers tested radiation therapy as a bridging therapy for patients with relapsed/refractory diffuse large B-cell lymphoma during the interval between T-cell collection and final CAR T administration.

One FDA-Approved test analyzes 324 cancer-related genes

FoundationOne^®CDx analyzes all recommend genomic biomarkers for solid tumors, including companion diagnostic indications with direct paths to therapy. This one test can help guide therapy selection and clinical trial options for more patients.

Read more.

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.